NIKA PHARMACEUTICALS INC. NIKA
Set alert
0.35 USD 0.00 0.00%
At close · Oct 29
0.35 Day range 0.35
0.202 52-week range 0.769
- YTD
- -7.92%
- 1 year
- +16.59%
- Open
- 0.35
- Prev close
- 0.35
- Mkt cap
- 366.99M
- Vol
- 2.50K
- Avg vol
- 162
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.35
- High
- 0.35
Financial health
Altman Z-Score
-691.97 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -3801×
FY 2020 5y median -3801× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B -1338×
FY 2020 5y median -2342× FY 2025
P/FCF -4999×
FY 2020 5y median -4999× FY 2025
EV/EBITDA -5212×
FY 2020 5y median -5212× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -0.0%
FY 2020 5y median -0.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE 25.7%
FY 2020 5y median 62.3% FY 2025
ROIC 25.7%
FY 2020 5y median -534.1% FY 2025
ROA -363.9%
FY 2020 5y median -534.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income 20.2%
FY 2020 FY 2025
EPS (diluted) 0.0%
FY 2020 FY 2025
Free Cash Flow 42.7%
FY 2020 FY 2025
Financial Health
Current Ratio 0.1×
FY 2020 5y median 0.1× FY 2025
Quick Ratio 0.1×
FY 2020 5y median 0.1× FY 2025
Debt / Equity 0.0×
FY 2020 5y median -1.0× FY 2025
Net Debt / EBITDA 0.0×
FY 2020 5y median -1.3× FY 2025
Interest Coverage 0.0×
FY 2020 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31